Dr. Marc Breton, PhD
Claim this profileUniversity of Virginia
Studies Type 1 Diabetes
Studies Diabetes
5 reported clinical trials
7 drugs studied
Affiliated Hospitals
University Of Virginia
University Of Virginia Center For Diabetes Technology
Clinical Trials Marc Breton, PhD is currently running
Artificial Pancreas
for Type 1 Diabetes
This study designed to assess changes in control of Type 1 Diabetes in pubertal adolescents over a two year period. There are two arms/substudies, the first being a longitudinal randomized controlled trial and the second an observational study.
Recruiting1 award N/A16 criteria
Fully Closed Loop System
for Type 1 Diabetes
Protocol Overview/Synopsis This study will be conducted at 3 sites, with each site performing a session with up to 6 participants with a lower HbA1c (\<8.0%) in one of 3 age categories (26-60, 18-25, or 14-17 years) followed by a session of up to 6 additional participants with a higher HbA1c (8.0-12.0%) with the same age categories (26-60, 18-25, or 14-17 years). The trial will aim to complete a total of 36 participants: 12 total participants within each age category and 18 participants within each HbA1c category; 12 participants at each site. The study may enroll up to 70 participants to account for dropouts across the study. The study will be performed for 5 days and 4 nights at a local hotel/rental. Following the hotel session, participants will undergo a 7 day/6-night remote monitored at-home use session. The study will also conduct a two-week control period gathering data on glycemic control and insulin administration with the participants usual care therapy. Participants will be randomized 1:1, stratified by age cohort, to either group A (control period prior to AIDANET use) or group B (control period after AIDANET use).
Recruiting1 award N/A17 criteria
More about Marc Breton, PhD
Clinical Trial Related1 year of experience running clinical trials · Led 5 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Marc Breton, PhD has experience with
- AIDANET System
- AI-based Advisor System
- Artificial Pancreas (AP)
- CGM-based Advisory System
- Sensor-Augmented Pump Therapy
- Sensor Augmented Mode
Breakdown of trials Marc Breton, PhD has run
Type 1 Diabetes
Type 2 Diabetes
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Marc Breton, PhD specialize in?
Marc Breton, PhD focuses on Type 1 Diabetes and Diabetes. In particular, much of their work with Type 1 Diabetes has involved treating patients, or patients who are undergoing treatment.
Is Marc Breton, PhD currently recruiting for clinical trials?
Yes, Marc Breton, PhD is currently recruiting for 2 clinical trials in Charlottesville Virginia. If you're interested in participating, you should apply.
Are there any treatments that Marc Breton, PhD has studied deeply?
Yes, Marc Breton, PhD has studied treatments such as AIDANET system, AI-based Advisor system, Artificial Pancreas (AP).
What is the best way to schedule an appointment with Marc Breton, PhD?
Apply for one of the trials that Marc Breton, PhD is conducting.
What is the office address of Marc Breton, PhD?
The office of Marc Breton, PhD is located at: University of Virginia, Charlottesville, Virginia 22904 United States. This is the address for their practice at the University of Virginia.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.